Gastrointestinal Cancer News

Patients with resected pancreatic cancer who did not receive preoperative therapy should be offered 6 months of adjuvant chemotherapy in the absence of medical or surgical contraindications, according to an updated ASCO clinical practice guideline published in Journal of Clinical Oncology.

Researchers estimate that undergoing colonoscopy within the previous 10 years prevented death from colorectal cancer in about 50,400 Americans and about 25,600 Germans aged 55 to 79 years between 2008 and 2011.

The FDA announced several decisions related to hematology and oncology therapies and devices in the past month.

AMSTERDAM — Curing patients with cirrhosis of hepatitis C virus could alter the inflammatory milieu and have an impact on the way CD8+ T-cells surveil potential carcinoma, according to data presented at the International Liver Congress.

AMSTERDAM — Unexpectedly high hepatocellular carcinoma recurrence rates were reported among patients who achieved sustained virologic response after receiving direct-acting antiviral therapy, according to data presented at the International Liver Congress.

AMSTERDAM — When adjusted for age and severity of liver disease, occurrence and recurrence of hepatocellular carcinoma after curing hepatitis C virus showed no difference between treatment with interferon or direct-acting antivirals, according to an expert at the International Liver Congress.

As we continue to see the success of direct-acting antiviral therapy in treating hepatitis C virus, we must be aware of any potential complications from the underlying liver disease after successful treatment, especially hepatocellular carcinoma.

Certain strains of gut microbiota are associated with colorectal cancer, and could be used as a non-invasive, accurate and cost-saving diagnostic test, according to new research published in Gut.

A phase 2 trial designed to evaluate tarextumab for the treatment of small cell lung cancer failed to meet its primary and secondary endpoints, according to the drug’s manufacturer.

More adults underwent recommended colorectal cancer screening in 2015 than adults did in 2000, according to an analysis of the 2015 National Health Interview Survey.